Ventyx Biosciences Inc (VTYX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Raju S. Mohan
Employees:
30
662 ENCINITAS BLVD., STE. 250, ENCINITAS, CA 92024
(858) 945-2393

Ventyx Biosciences, Inc. develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus.

Data derived from most recent annual or quarterly report
Market Cap 1.957 Billion Shares Outstanding56.637 Million Avg 30-day Volume 1.008 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.59
Price to Revenue0.0 Debt to Equity0.0 EBITDA-90.887 Million
Price to Book Value4.7029 Operating Margin0.0 Enterprise Value1.391 Billion
Current Ratio11.732 EPS Growth0 Quick Ratio11.565
1 Yr BETA 1.4167 52-week High/Low 47.25 / 11.07 Profit Margin0.0
Operating Cash Flow Growth-156.0597 Altman Z-Score29.0615 Free Cash Flow to Firm 0
Earnings Report2023-05-11
View SEC Filings from VTYX instead.

View recent insider trading info

Ventyx Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding VTYX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VTYX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-21 by SUBRAMANIAM SOMU
  • 4: filed on 2023-03-21 by NSV PARTNERS III GP LLC
  • 5: filed on 2023-02-13 by GUJRATHI SHEILA
  • 4: filed on 2023-01-24 by WHITE WILLIAM RICHARD
  • 4: filed on 2023-01-12 by CADORET-MANIER ONAIZA
  • 4: filed on 2023-01-12 by HULME ALLISON
  • 3: filed on 2023-01-12 by CADORET-MANIER ONAIZA
  • 3: filed on 2023-01-12 by HULME ALLISON
  • 4: filed on 2022-12-23 by MOHAN RAJU
  • 4: filed on 2022-12-23 by NUSS JOHN

    • Events (8k)

  • 8-K: filed on 2023-03-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-26:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-12:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-30:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SUBRAMANIAM SOMU

    • Director
    • 10% Owner
    		 11,824,143 2023-03-17 7

    NSV PARTNERS III LP

    NSV PARTNERS III GP LLC

    • 10% Owner
    		 11,824,143 2023-03-17 5

    WHITE WILLIAM RICHARD

    • Director
    		 119,120 2023-01-23 2

    KRUEGER CHRISTOPHER W CHIEF BUSINESS OFFICER

    • Officer
    		 126,875 2023-01-17 6

    NUSS JOHN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 126,875 2023-01-17 5

    AUSTER MARTIN CHIEF FINANCIAL OFFICER

    • Officer
    		 126,875 2023-01-17 2

    MOHAN RAJU CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 331,625 2023-01-17 4

    SANDBORN WILLIAM J. SEE REMARKS

    • Officer
    		 140,000 2023-01-17 4

    HULME ALLISON

    • Director
    		 0 2023-01-11 2

    CADORET-MANIER ONAIZA

    • Director
    		 0 2023-01-11 2

    GUJRATHI SHEILA

    • Director
    		 0 2022-12-31 2

    NSV PARTNERS III LP

    NSV PARTNERS III GP LLC

    NSV INVESTMENTS I, L.P.

    • 10% Owner
    		 13,274,786 2022-12-13 1

    VENBIO GLOBAL STRATEGIC FUND III, L.P.

    VENBIO GLOBAL STRATEGIC GP III, L.P.

    VENBIO GLOBAL STRATEGIC GP III, LTD

    ADELMAN ROBERT J

    GOODMAN COREY S

    • 10% Owner
    • SEE REMARKS
    		5,011,536 2022-06-09 1

    ROYSTON AARON

    • Director
    		 13,301 2022-06-09 1

    GASTER RICHARD

    • Director
    		 13,301 2022-06-09 1

    CHOKSEY JIGAR

    • Director
    		 0 2022-06-09 2

    DRAPPA JORN CHIEF MEDICAL OFFICER

    • Officer
    		 145,000 2022-02-04 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND III LP

    • 10% Owner
    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		1,410,303 2021-10-25 0

    NSV INVESTMENTS I, L.P.

    • 10% Owner
    		 0 2021-10-20 1

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NSV PARTNERS III LP - > 10% Owner see footnotes

    NSV PARTNERS III GP LLC - > 10% Owner see footnotes

    		2023-03-21 18:10:52 -0400 2023-03-17 J 591,276 d 11,824,143 indirect -3.2848 0.0 1 -3.2848 2

    SUBRAMANIAM SOMU - Director - > 10% Owner see footnotes

    		2023-03-21 18:13:30 -0400 2023-03-17 J 591,276 d 11,824,143 indirect -3.2848 0.0 1 -3.2848 2

    SUBRAMANIAM SOMU - Director - > 10% Owner see footnotes

    		2023-03-07 20:48:56 -0500 2023-03-03 J 559,367 d 12,415,419 indirect -6.8478 -16.0305 0.0 1 -16.0305 6

    NSV PARTNERS III LP - > 10% Owner see footnotes

    NSV PARTNERS III GP LLC - > 10% Owner see footnotes

    		2023-03-07 20:51:50 -0500 2023-03-03 J 559,367 d 12,415,419 indirect -6.8478 -16.0305 0.0 1 -16.0305 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 22:15:04 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 21:45:05 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 21:15:04 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 20:45:06 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 20:15:05 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 19:45:05 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 19:15:05 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 18:45:06 UTC 4.2992 0.5208 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 18:15:06 UTC 4.2992 0.5208 1000000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 17:45:06 UTC 4.2992 0.5208 1000000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 17:15:05 UTC 4.2992 0.5208 1000000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 16:45:05 UTC 4.2528 0.5672 1000000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 16:15:05 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 15:45:05 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 15:15:06 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 14:45:06 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 14:15:06 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 13:45:05 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 13:15:05 UTC 4.2528 0.5672 1100000
    VENTYX BIOSCIENCES INC VTYX 2023-03-29 12:45:05 UTC 4.2528 0.5672 1100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    RBB Fund, Inc.- Boston Partners Long/Short Research Fund VTYX -20475.0 shares, $-593570.25 2022-11-30 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VTYX -406.0 shares, $-13312.74 2022-12-31 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund VTYX -2884.0 shares, $-121128.0 2023-01-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VTYX -1709.0 shares, $-71778.0 2023-01-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments